Early public research funding response to COVID-19 pandemic in Brazil.

Autor:	Campo KN; Universidade Federal de Goiás, Faculdade de Ciências e Tecnologia, Aparecida de Goiânia, SP, Brasil., Rodrigues ICP; Universidade Estadual de Campinas, Faculdade de Engenharia Mecânica, Campinas, SP, Brasil., Lopes ÉSN; Universidade Estadual de Campinas, Faculdade de Engenharia Mecânica, Campinas, SP, Brasil., Gabriel LP; Universidade Estadual de Campinas, Faculdade de Ciências Aplicadas, Limeira, SP, Brasil.
Jazyk:	angličtina
Zdroj:	Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2020 Sep 21; Vol. 53, pp. e20200522. Date of Electronic Publication: 2020 Sep 21 (Print Publication: 2020).
DOI:	10.1590/0037-8682-0522-2020
Abstrakt:	Introduction: This study investigated the role of early public research funding regarding the COVID-19 pandemic in Brazil. Methods: We examined the budget for research projects relating to the number of cases and deaths and the relationship between each federal unit, gross domestic product (GDP) per capita, and the national GDP per capita. Results: Using data from the websites of official funding agencies and the Brazilian government, we found that, in the first four months since the first case in Wuhan, China (December 31, 2019), around US$ 38.3 million were directed to public funding for scientific investigations against the COVID-19 pandemic. However, only 11 out of 27 federal units provided funding during the initial stages of the outbreak, and those that did provide financing were not necessarily the units having the most inhabitants, highest GDP, or the greatest number of cases. The areas of research interest were also identified in the funding documents; the most common topic was "diagnosis" and the least common was "equipment for treatment." Conclusions: Brazilian researchers had access to funding opportunities for projects against COVID-19. However, strategies to minimize the economic impacts of COVID-19 are crucial in mitigating or avoiding substantial financial and social shortcomings, particularly in terms of an emerging market such as Brazil.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu